ProCE Banner Activity

IO Combinations in Early or Intermediate-Stage HCC: Current Evidence and Ongoing Trials

Slideset Download
Download this slideset from Peter R. Galle, MD, PhD, to see the latest data on immunotherapy treatment options for patients with early or intermediate-stage hepatocellular carcinoma.

Released: October 14, 2020

Expiration: October 13, 2021

No longer available for credit.

Share

Faculty

Peter R. Galle

Peter R. Galle, MD, PhD

Chairman
First Department of Internal Medicine
University Medical Center
Mainz, Germany

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Peter R. Galle, MD, PhD

Chairman
First Department of Internal Medicine
University Medical Center
Mainz, Germany